eMERGE is a national network organized and funded by the National Human Genome Research Institute (NHGRI) that combines DNA biorepositories with electronic medical record (EMR) systems for large scale, high-throughput genetic research in support of implementing genomic medicine.
about eMERGE (blue) (web)
popular tools (click on a button below)
 phekb big web
  myresults big web
  sphinx web
CDS KB
A knowledgebase of clinical
decision support that drives
precision medicine
 		 consent big web
  phewas big web
Recent Publications
Mizuno T, Dong M, Taylor ZL, Ramsey LB, Vinks AA. Clinical implementation of pharmacogenetics and model-informed precision dosing to improve patient care. British journal of clinical pharmacology. 2020 Jun 11;.
Lynch JA, Sharp RR, Aufox SA, Bland ST, Williams JL, et al. Understanding the Return of Genomic Sequencing Results Process: Content Review of Participant Summary Letters in the eMERGE Research Network. Journal of personalized medicine. 2020 May 13;10(2).
Kochan DC, Winkler E, Lindor N, Shaibi GQ, Kullo IJ, et al. Challenges in returning results in a genomic medicine implementation study: the Return of Actionable Variants Empirical (RAVE) study. NPJ genomic medicine. 2020;5:19.
Mosley JD, Levinson RT, Farber-Eger E, Edwards TL, Wells QS, et al. The polygenic architecture of left ventricular mass mirrors the clinical epidemiology. Scientific reports. 2020 May 5;10(1):7561.
In the News

Here's what's happening with eMerge:

01
JUL

Read the full press release here. Congratulations to all the sites in the next round of eMERGE! The new clinical sites will be led by: Iftikhar J. Kullo, M.D., at Mayo Clinic, Rochester, Minnesota Dan M. Roden, M.D., at Vanderbilt University Medical Center, Nashville, Tennessee Elizabeth W. Karlson, M.D., at Brigham and Women’s Hospital, Boston Rex […]
08
MAY

The eMERGE Network is excited to share that the MCS NT304, Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in the eMERGE Network; was published on May 7th to American Journal of Human Genetics.
24
MAR

Two companion RFAs for the PRS Diversity Consortium are now published: Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Study Sites (U01 Clinical Trial Not Allowed): https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-20-001.html Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Coordinating Center (U01 Clinical Trial Not Allowed): https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-20-002.html The goal […]
27
FEB

Notice to Encourage Eligible NHGRI Awardees to Apply for PA-18-906 “Research Supplements to Promote Diversity in Health-Related Research” https://grants.nih.gov/grants/guide/notice-files/NOT-HG-19-010.html PIs of active NHGRI research grants can apply; identify eligible individuals, including those from underrepresented groups, for support and mentorship under the auspices of this supplement opportunity. Supplement can support individuals from the undergraduate to the […]